Atlas Trials

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up

Clinical trial NCT02526030 · COMPLETED

Trial details

NCT number
NCT02526030
Sponsor
Fundación Marques de Valdecilla
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaPsychotic Disorders
Start date
2008-10-01
Primary completion
2014-02-01
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.